Filtered Search Results
R&D Systems™ Recombinant Human EGF Protein
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity
| Purity or Quality Grade | >97%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie™ Blue Staining. |
|---|---|
| Conjugate | Unconjugated |
| Molecular Weight (g/mol) | M.W. (Observed): 6 kDa, reducing conditions; M.W. (theoretical): 6 kDa |
| Gene Symbol | EGF |
| Endotoxin Concentration | <0.10 EU / 1 μg of the protein by the LAL method. |
| Storage Requirements | Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20°C to -70°C as supplied. 1 month, 2°C to 8°C under sterile conditions after reconstitution. 3 months, -20°C to -70°C under sterile conditions after reconstitution. |
| For Use With (Application) | Bioactivity |
| Protein | EGF |
| Source | E. coli-derived human EGF protein Asn971-Arg1023, with an N-terminal Met |
| Name | EGF |
| Accession Number | P01133 |
| Gene ID (Entrez) | 1950 |
| Formulation | Lyophilized from a 0.2 μm filtered solution in PBS. |
| Reconstitution | Reconstitute at 500 μg/mL in sterile PBS. |
| Recombinant | Recombinant |
R&D Systems™ Recombinant Human FGF basic/FGF2/bFGF (146 aa) Protein
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity
R&D Systems™ Recombinant Human FGF basic/FGF2/bFGF (146 aa) Protein
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity
R&D Systems™ Recombinant Human TNF-alpha Protein
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity
R&D Systems™ Recombinant Human IL-6 Protein
A New rh IL-6 is Available! The new protein has ∼2 fold better activity and is HEK293 expressed!
| Purity or Quality Grade | >97%, by SDS-PAGE under reducing conditions and visualized by silver stain. |
|---|---|
| Conjugate | Unconjugated |
| Molecular Weight (g/mol) | M.W. theroretical: 20.9 kDa |
| Gene Symbol | IL6 |
| Endotoxin Concentration | <0.10 EU / 1 μg of the protein by the LAL method. |
| Storage Requirements | Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20°C to -70°C as supplied. 1 month, 2°C to 8°C under sterile conditions after reconstitution. 3 months, -20°C to -70°C under sterile conditions after reconstitution. |
| For Use With (Application) | Bioactivity |
| Protein | IL-6 |
| Source | E. coli-derived human IL-6 protein Pro29-Met212 |
| Name | IL-6 |
| Accession Number | Q75MH2 |
| Gene Alias | B-cell differentiation factor, B-cell stimulatory factor 2, BSF2, BSF-2, CDF, CTL differentiation factor, HSF, hybridoma growth factor, IFNB2, IFN-beta-2, IL6, IL-6, Interferon beta-2, interleukin 6 (interferon, beta 2), interleukin BSF-2, interleukin-6, MGI-2A |
| Gene ID (Entrez) | 3569 |
| Formulation | Lyophilized from a 0.2 μm filtered solution in PBS and NaCl. |
| Recombinant | Recombinant |
R&D Systems™ Recombinant Human TNF-alpha, Biotinylated Protein
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity
R&D Systems™ Recombinant Human IL-10 Protein
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity
| Purity or Quality Grade | >97%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie™ Blue Staining. |
|---|---|
| Conjugate | Unconjugated |
| Molecular Weight (g/mol) | 18.6 kDa |
| Gene Symbol | IL10 |
| Endotoxin Concentration | <0.10 EU per 1 μg of the protein by the LAL method. |
| Storage Requirements | Manual defrost freezer; Avoid repeated freeze-thaw cycles; 12 mo. from receipt, -20 to -70°C as supplied; 1 mo, 2 to 8°C under sterile conditions after reconstitution; 3 mo, -20 to -70°C under sterile conditions after reconstitution |
| For Use With (Application) | Bioactivity |
| Source | <EM>Spodoptera frμgiperda</EM>, <EM>Sf</EM> 21 (baculovirus)-derived human IL-10 protein Ser19-Asn178 |
| Accession Number | P22301 |
| Regulatory Status | RUO |
| Gene Alias | CSIF, CSIFMGC126450, Cytokine synthesis inhibitory factor, GVHDS, IL10, IL10A, IL-10MGC126451, interleukin 10, interleukin-10, TGIF |
| Gene ID (Entrez) | 3586 |
| Formulation | Lyophilized from a 0.2 μm filtered solution in PBS with BSA as a carrier protein. *1 mg pack size (01M) is supplied as a 0.2 μm filtered solution in PBS with BSA as a carrier protein. |
| Reconstitution | Reconstitute at 50 μg/mL in sterile PBS containing at least 0.1% human or bovine serum albumin. |
| Cross Reactivity | IL-10 |
| Species | Human |
R&D Systems™ Recombinant Human FGF basic/FGF2/bFGF (146 aa) Protein
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity
R&D Systems™ Recombinant Human TNF-alpha Protein
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity
R&D Systems™ Recombinant Human VEGF 165 Protein
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity
| Purity or Quality Grade | 97%, by SDS-PAGE with silver staining. |
|---|---|
| Conjugate | Unconjugated |
| Molecular Weight (g/mol) | observed_molecular_weight: 20-22 kDa, under reducing conditions. 39-42 kDa, under non-reducing conditions. |
| Gene ID (Entrez) | 7422 |
| Storage Requirements | Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -20 to -70° C under sterile conditions after reconstitution. |
| Source | Spodoptera frugiperda,Sf 21 (baculovirus)-derived human VEGF protein Ala27-Arg191 |
| Recombinant | Recombinant |
| Name | VEGF 165 |
R&D Systems™ Recombinant Human FGF basic/FGF2/bFGF (146 aa) Protein
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity
R&D Systems™ Recombinant Human FGF basic/FGF2/bFGF (145 aa) Protein
Measured in a cell proliferation assay using NR6R-3T3 mouse fibroblast cells.
| Purity or Quality Grade | >95%, by SDS-PAGE under reducing conditions and visualized by silver stain. |
|---|---|
| Conjugate | Unconjugated |
| Molecular Weight (g/mol) | M.W. (theoretical): 16 kDa |
| Gene Symbol | FGF2 |
| Endotoxin Concentration | <0.01 EU / 1 μg of the protein by the LAL method. |
| Storage Requirements | Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20°C to -70°C as supplied. 1 month, 2°C to 8°C under sterile conditions after reconstitution. 3 months, -20°C to -70°C under sterile conditions after reconstitution. |
| For Use With (Application) | Bioactivity |
| Protein | FGF basic/FGF2/bFGF |
| Source | E. coli-derived human FGF basic/FGF2/bFGF protein Ala144-Ser288 |
| Accession Number | NP_001997 |
| Gene ID (Entrez) | 2247 |
| Formulation | Lyophilized from a 0.2 μm filtered solution in Tris-HCl and NaCl. |
| Reconstitution | Reconstitute at 100 μg/mL in sterile PBS. |
| Species | Human |
| Purity or Quality Grade | >97%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie™ Blue Staining. |
|---|---|
| Conjugate | Unconjugated |
| Molecular Weight (g/mol) | M.W. (Observed): 13 kDa, under reducing conditions., M.W. (Theoretical): 15.1 kDa |
| Endotoxin Concentration | <0.10 EU per 1μg of the protein by the LAL method. |
| Storage Requirements | Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 °C as supplied. 1 month, 2 to 8 °C under sterile conditions after reconstitution. 3 months, -20 to -70 °C under sterile conditions after reconstitution. |
| For Use With (Application) | Bioactivity |
| Protein | IL-4 |
| Source | E. coli-derived human IL-4 protein His25-Ser153, with an N-terminal Met |
| Accession Number | P05112.1 |
| Gene Alias | B cell growth factor 1, BCDF, B-cell stimulatory factor 1, BCGF1, BCGF-1, binetrakin, BSF1, BSF-1, IL4, IL-4B_cell stimulatory factor 1, IL4E12, interleukin 4, interleukin-4, Lymphocyte stimulatory factor 1, MGC79402, Pitrakinra |
| Gene ID (Entrez) | 3565 |
| Formulation | Lyophilized from a 0.2μm filtered solution in PBS with Trehalose. |
| Reconstitution | Reconstitute the 10μg size at 100μg/mL in PBS. Reconstitute all other sizes at 500μg/mL in PBS. |
| Species | Human |
R&D Systems™ Recombinant Human GDNF Protein
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity, Binding Activity
| Purity or Quality Grade | 97%, by SDS-PAGE under reducing conditions and visualized by silver stain. |
|---|---|
| Conjugate | Unconjugated |
| Molecular Weight (g/mol) | 11.6 kDa (monomer) |
| Gene ID (Entrez) | 2668 |
| Structural Form | Disulfide-linked homodimer |
| Storage Requirements | Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -20 to -70° C under sterile conditions after reconstitution. |
| Source | Mouse myeloma cell line,NS0-derived human GDNF protein Arg109-Ile211 |
| Recombinant | Recombinant |
| Name | GDNF |